Table 2.
Morbidity and mortality after cTACE and DEB-TACE
| Postinterventional course | Overall | cTACE | DEB-TACE | P-value |
|---|---|---|---|---|
| Mortality | ||||
| Within 30 days, n (%) | 3 (9.4) | 2 (11.1) | 1 (7.1) | 0.7024 |
| Analgetic requirements | ||||
| Data available, n | 30 | 16 | 14 | |
| Pain medication applied, n (%) | 15 (50.0) | 5 (31.3) | 10 (71.1) | 0.0281 |
| iv application, n (%) | 10 (33.3) | 2 (12.5) | 8 (57.1) | 0.0097 |
| Opiate, n (%) | 10 (33.3) | 2 (12.5) | 8 (57.1) | 0.0097 |
| Pyrexia | ||||
| Data available, n | 27 | 16 | 14 | |
| ≥38.0°C/100.4°F, n (%) | 15 (55.6) | 8 (50.0) | 7 (50.0) | 1.0000 |
| Hospital stay after TACE (d) | ||||
| Mean | 3.2 | 3.7 | 3.0 | 0.2122 |
Abbreviations: cTACE, conventional transarterial chemoembolization; DEB-TACE, transarterial chemoembolization with drug-eluting beads; iv, intravenous; TACE, transarterial chemoembolization; d, days.